-Randomized Phase 3 Clinical Trial with ADCETRIS Met Primary Endpoint, Demonstrating a Statistically Significant Improvement in Modified Progression-Free Survival- -Abstract to be Submitted for Presentation at the 2017 ASH Annual Meeting; Regulatory
Two recently-signed agreements will transfer Takeda’s measles and acellular pertussis vaccine technologies to India-based multi-national company Biological E. Limited (“BEâ€) to develop low-cost combination vaccines including diphth
AT&T, China Mobile, China Unicom, China Telecom, Deutsche Telekom, Verizon and Vodafone Launch Mobile IoT (LPWA) Networks
Primacom to double broadband speeds by efficiently leveraging SES Networks’ fully-managed Maritime+ service
Indian Business Travel Market Value to Rise to USD 93 Billion by 2030
Respondents cite hybrid IT as a preferred strategy for leveraging current robust ECC release as foundational system of record; More than 50 percent of respondents estimate S/4HANA reimplementation costs between $10 and $100 million
Authored by:- Prof VS Rao, President, NIIT University
Ruchi 'Saral Yoga' Abhiyaan integrates daily yoga sessions for employees into corporate routine
Its ingenious air-purification technology validated to reduce airway inflammation in asthmatic patients
The firm makes strategic changes within as the agency continues to grow globally
First-of-its-kind Social Media Analytics Platform
Helps companies accelerate the development of new medications by reducing the failure rate during the clinical phase